Skip to content
Shuttingdown

Tempest Therapeutics, Inc.

Pharmaceutical Preparations · BRISBANE · CA

Distress signal

Moderate confidence (50%)

Updated Oct 14, 2026, 12:02 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: Tempest Therapeutics, Inc. received a delisting notice from its exchange (May 19, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Tempest Therapeutics, Inc. received a delisting notice from its exchange

    May 19, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Stockholders Equity Requirement On May 19, 2026, Tempest Therapeutics, Inc. (the Company ) received a deficiency letter from the Listing Qualifications Department (the Staff ) of the Nasdaq Stock Market ( Nasdaq ) notifying the Company that it is not in compliance with the minimum stockholders equity requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires companies listed on the Nasdaq Capital Market to maintain stockholders equity of a…”
  2. Tempest Therapeutics, Inc. received a delisting notice from its exchange

    Jan 8, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed in Tempest Therapeutics, Inc. s (the Company s ) definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on December 31, 2025, the Company has scheduled its 2025 Annual Meeting of Stockholders to be held on January 27, 2026 (the 2025 Annual Meeting ). Although the 2025 Annual Meeting has been scheduled, on January 8, 2026, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LL…”

Company information

Founded
—
Employees (estimate)
—
Industry
Pharmaceutical Preparations
Subindustry
—
Listing
SEC lists the ticker TPST on Nasdaq.
SEC CIK
0001544227
Website
—
LinkedIn
—
Headquarters
BRISBANE, CA
Also known as
Millendo Therapeutics, Inc., OvaScience, Inc.
Legal entities
Tempest Therapeutics, Inc.

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Tempest Therapeutics, Inc. — Pharmaceutical Preparations (SIC 2834) — BRISBANE, CA
    View source record
  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Stockholders Equity Requirement On May 19, 2026, Tempest Therapeutics, Inc. (the Company ) received a deficiency letter from the Listing Qualifications Department (the Staff ) of the Nasdaq Stock Market ( Nasdaq ) notifying the Company that it is not in compliance with the minimum stockholders equity requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires companies listed on the Nasdaq Capital Market to maintain stockholders equity of a…
    View source record
  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed in Tempest Therapeutics, Inc. s (the Company s ) definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on December 31, 2025, the Company has scheduled its 2025 Annual Meeting of Stockholders to be held on January 27, 2026 (the 2025 Annual Meeting ). Although the 2025 Annual Meeting has been scheduled, on January 8, 2026, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LL…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:14 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:35 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:46 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:54 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.